Traumatic Direct Transfusion Devices LLC

Ovesco Endoscopy AG is a research-based medical device company specializing in flexible endoscopy and endoluminal surgery, dedicated to developing, manufacturing, and marketing innovative instruments and systems for treating gastrointestinal diseases. With a strong emphasis on comprehensive procedures, Ovesco supports healthcare professionals from training through intervention, offering advanced solutions such as the OTSC system for gastrointestinal hemorrhage treatment and endoscopic digestive organ wall closure. Headquartered in Tuebingen, Germany, Ovesco operates additional locations in France and the USA, providing its products to patients in over 70 countries worldwide. The company's commitment to innovation is exemplified by its expanding portfolio, which includes novel resection techniques like FTRD and diagnostic sensor capsules such as the HemoPill. Generated from the website

Liquidia Technologies is developing highly precise particle-based vaccines and therapeutics for the prevention and treatment of human disease. Combining a deep understanding of particle-based drug development with breakthrough small molecule and biological therapeutics, Liquidia is engineering vaccines and therapies that have the potential to dramatically improve the quality of human life. The company was founded in 2004 and is located in Research Triangle Park, North Carolina.